US20130218013A1 - Ultrasound Medical System and Method - Google Patents
Ultrasound Medical System and Method Download PDFInfo
- Publication number
- US20130218013A1 US20130218013A1 US13/752,151 US201313752151A US2013218013A1 US 20130218013 A1 US20130218013 A1 US 20130218013A1 US 201313752151 A US201313752151 A US 201313752151A US 2013218013 A1 US2013218013 A1 US 2013218013A1
- Authority
- US
- United States
- Prior art keywords
- ultrasound
- tissue
- treatment system
- measuring sensor
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B17/22004—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves
- A61B17/22012—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement
- A61B17/2202—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement the ultrasound transducer being inside patient's body at the distal end of the catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/06—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating caused by chemical reaction, e.g. moxaburners
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/08—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by means of electrically-heated probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/1815—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using microwaves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/053—Measuring electrical impedance or conductance of a portion of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/13—Tomography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/36—Image-producing devices or illumination devices not otherwise provided for
- A61B90/37—Surgical systems with images on a monitor during operation
- A61B2090/378—Surgical systems with images on a monitor during operation using ultrasound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/42—Details of probe positioning or probe attachment to the patient
- A61B8/4272—Details of probe positioning or probe attachment to the patient involving the acoustic interface between the transducer and the tissue
- A61B8/4281—Details of probe positioning or probe attachment to the patient involving the acoustic interface between the transducer and the tissue characterised by sound-transmitting media or devices for coupling the transducer to the tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/44—Constructional features of the ultrasonic, sonic or infrasonic diagnostic device
- A61B8/4483—Constructional features of the ultrasonic, sonic or infrasonic diagnostic device characterised by features of the ultrasound transducer
Definitions
- the present invention relates generally to ultrasound, and more particularly to ultrasound medical systems and methods.
- Known medical methods include using ultrasound imaging (at low power) of patients to identify patient tissue for medical treatment and include using ultrasound (at high power) to ablate identified patient tissue by heating the tissue.
- Known ultrasound medical systems and methods include deploying an ultrasound end effector having an ultrasound transducer outside the body to break up kidney stones inside the body, endoscopically inserting an ultrasound end effector having an ultrasound transducer in the rectum to medically destroy prostate cancer, laparoscopically inserting an ultrasound end effector having an ultrasound transducer in the abdominal cavity to medically destroy a cancerous liver tumor, intravenously inserting a catheter ultrasound end effector having an ultrasound transducer into a vein in the arm and moving the catheter to the heart to medically destroy diseased heart tissue, and interstitially inserting a needle ultrasound end effector having an ultrasound transducer needle into the tongue to medically destroy tissue to reduce tongue volume to reduce snoring.
- Rotatable ultrasound end effectors are known wherein an ultrasound transducer is non-rotatably attached to a shaft whose distal end is circumferentially and longitudinally surrounded by a sheath having a longitudinal axis and having an acoustic window. Water between the shaft and the sheath provides acoustic coupling between the ultrasound transducer and the acoustic window.
- the shaft is rotatable about the longitudinal axis with respect to the sheath.
- the sheath is non-rotatably attached to a handpiece.
- RF radio-frequency
- a method of the invention is for ultrasonically treating a lesion in a patient and includes steps a) through e).
- Step a) includes obtaining an interstitial end effector having a distal end, including a medical ultrasound transducer assembly having at least one medical-treatment ultrasound transducer, and including at least one end-effector-tissue-track ablation device.
- Step b) includes inserting the interstitial end effector into the patient creating a tissue track which is surrounded by patient tissue and which ends at the distal end of the inserted interstitial end effector.
- Step c) includes ultrasonically ablating the lesion using the at-least-one medical-treatment ultrasound transducer.
- Step d) includes using the at-least-one end-effector-tissue-track ablation device to ablate the patient tissue surrounding the tissue track along substantially the entire tissue track.
- Step e) includes withdrawing the end effector from the patient.
- An embodiment of the invention is an ultrasound medical system including an interstitial end effector.
- the interstitial end effector is interstitially insertable into patient tissue, includes at least one medical-treatment ultrasound transducer, and includes at least one end-effector-tissue-track ablation device.
- having an interstitial end effector with a medical-treatment ultrasound transducer and an end-effector-tissue-track ablation device allows ultrasonic ablation of a lesion using the medical-treatment ultrasound transducer and allows ablation of patient tissue surrounding the tissue track as the interstitial end effector is withdrawn from the patient to help reduce the possibility of excessive bleeding and/or tissue contamination.
- the present invention has, without limitation, application in conventional interstitial, endoscopic, laparoscopic, and open surgical instrumentation as well as application in robotic-assisted surgery.
- FIG. 1 is a perspective view of a first embodiment of the present invention showing an ultrasound medical system which includes an end effector, a handpiece, and a controller;
- FIG. 2 is a schematic cross-sectional view of a first embodiment of the end effector and the handpiece of the ultrasound medical system of FIG. 1 showing a medical ultrasound transducer assembly and two non-ultrasound tissue-property-measuring sensors;
- FIG. 3 is a view, as in FIG. 2 , but of a second embodiment of a handpiece and of an end effector having a medical ultrasound transducer assembly and two tines;
- FIG. 4 is a view, as in FIG. 2 , but of a third embodiment of an end effector having a medical ultrasound transducer assembly supported by a shaft and having a surrounding sheath, wherein the sheath includes two balloon portions;
- FIG. 5 is a block diagram view of a method of the invention for ultrasonically treating a lesion in a patient.
- FIG. 6 is a schematic view, partially in cross-section, of a fourth embodiment of an end effector which has a medical-treatment ultrasound transducer and three end-effector-tissue-track ablation devices and which can be used in one employment of the method of FIG. 5 .
- a first embodiment of the present invention is an ultrasound medical system 110 comprising an ultrasound end effector 112 and at least one non-ultrasound tissue-property-measuring sensor 114 and 116 .
- the ultrasound end effector 112 includes a medical ultrasound transducer assembly 118 having at least one medical-treatment ultrasound transducer 120 .
- the at-least-one non-ultrasound tissue-property-measuring sensor 114 and 116 is supported by the ultrasound end effector 112 and is disposable in contact with patient tissue 122 .
- a medical-treatment ultrasound transducer includes a medical-treatment-only ultrasound transducer and a medical-imaging-and-treatment ultrasound transducer.
- an ultrasound transducer has a single transducer element, and in another arrangement, an ultrasound transducer has a plurality (also called an array) of transducer elements.
- a medical ultrasound transducer assembly having at least one medical-treatment ultrasound transducer can also have at least one medical-imaging ultrasound transducer.
- the ultrasound end effector 112 includes a longitudinal axis 124 .
- the at-least-one non-ultrasound tissue-property-measuring sensor 114 and 116 includes a first non-ultrasound tissue-property-measuring sensor 114 and a second non-ultrasound tissue-property-measuring sensor 116 .
- the at-least-one medical-treatment ultrasound transducer 120 is disposed longitudinally between the first and second non-ultrasound tissue-property-measuring sensors 114 and 116 .
- the at-least-one non-ultrasound tissue-property-measuring sensor (e.g., 114 ) measures tissue temperature.
- the at-least-one non-ultrasound tissue-property-measuring sensor (e.g., 114 ) is chosen from the group consisting of a thermistor, a thermocouple, and combinations thereof.
- the at-least-one non-ultrasound tissue-property-measuring sensor e.g., 116 ) measures tissue electric impedance.
- the at-least-one non-ultrasound tissue-property-measuring sensor (e.g., 116 ) is chosen from the group consisting of a monopolar electrode, a bipolar electrode, and combinations thereof. It is noted that tissue temperature and/or tissue electric impedance is a measure of the degree of ultrasonic ablation of patient tissue, as can be appreciated by those skilled in the art.
- the ultrasound end effector 112 is an ultrasound interstitial end effector 126 which is interstitially insertable into patient tissue 122 and which has an exterior surface 128 .
- the at-least-one non-ultrasound tissue-property-measuring sensor 114 and 116 is attached to the ultrasound interstitial end effector 126 and is fixedly disposed substantially flush with the exterior surface 128 .
- the exterior surface 128 includes at least one balloon portion 130 and 132 which is expandable and contractible and which is expandable against patient tissue 122 to provide at least some stabilization of the ultrasound interstitial end effector 126 with respect to patient tissue 122 .
- the exterior surface 128 is the exterior surface of a sheath 134 and has first and second balloon portions 130 and 132 , wherein the first balloon portion 130 surrounds the medical ultrasound transducer assembly 118 and acts as an acoustic window, and wherein the second balloon portion 132 is longitudinally spaced apart from the medical ultrasound transducer assembly 118 .
- An acoustic coupling medium such as water, is disposable between the medical ultrasound transducer assembly 118 and the first balloon portion 130 and has been omitted from FIG. 2 for clarity.
- the first balloon portion 130 is omitted and the sheath 134 terminates before the medical ultrasound transducer assembly 118 which is exposed to patient tissue.
- the second balloon portion 132 is omitted.
- the at-least-one balloon portion 130 and 132 is contracted during tissue insertion and withdrawal of the ultrasound interstitial end effector 126 .
- Other constructions, arrangements, variations, and modifications are left to the artisan.
- the ultrasound end effector 112 is an ultrasound interstitial end effector 126 which is interstitially insertable into patient tissue 122 and which has an exterior surface 128 .
- the at least-one non-ultrasound tissue-property-measuring sensor 114 and 116 is deployable to extend away from the exterior surface into patient tissue 128 to provide at least some stabilization of the ultrasound interstitial end effector 126 with respect to patient tissue 122 and is retrievable to retract back toward the exterior surface 128 .
- the at-least-one non-ultrasound tissue-property-measuring sensor 114 and 116 is storable inside the exterior surface.
- the ultrasound medical system 110 also includes a handpiece 136 operatively connected to the ultrasound end effector 112 .
- the ultrasound end effector 112 has a longitudinal axis 124 and a shaft 138 , and the medical ultrasound transducer assembly 118 is supported by the shaft 138 .
- the shaft 138 is rotatable with respect to the handpiece 136 about the longitudinal axis 124 and is supported by bearings 139 .
- a motor 140 rotates the shaft 138 .
- the ultrasound medical system 110 includes a controller 142 operatively connected to the handpiece 136 via a cable 144 .
- a second embodiment of the present invention is an ultrasound medical system 210 comprising an ultrasound end effector 226 .
- the ultrasound end effector 226 has an exterior surface 228 .
- the ultrasound end effector 226 includes a medical ultrasound transducer assembly 218 having at least one medical-treatment ultrasound transducer 220 , and includes at least one tine 246 and 248 .
- the at-least-one tine 246 and 248 is deployable to extend away from the exterior surface into patient tissue to provide at least some stabilization of the ultrasound end effector 226 with respect to patient tissue and is retrievable to retract back toward the exterior surface 228 .
- the ultrasound end effector 226 is insertable into a patient.
- the ultrasound end effector 226 is an ultrasound interstitial end effector which is interstitially insertable into patient tissue.
- the ultrasound end effector is insertable into a patient in an endoscopic, laparoscopic, and/or open surgical manner.
- the ultrasound end effector is disposable on the outside of a patient. Other examples and variations are left to the artisan.
- the at-least-one tine 246 and 248 includes a plurality of tines.
- the at-least-one tine 246 and 248 is storable inside the exterior surface. It is noted that construction of deployable tines 246 and 248 in an ultrasound end effector 226 is within the level of skill of the artisan. In one arrangement, such deployment is accomplished using one or more of cables, levers, motors 249 , gearing, push rods and the like to move a tine partially out of, and back into, a lumen in the end effector. In one choice of materials, the tine comprises or consists essentially of Nitinol wire or nichrome wire.
- the at-least-one tine acts as an element chosen from the group consisting of an electrode, a thermistor, a thermocouple, an acoustic reflector, an acoustic absorber, an acoustic emitter, an acoustic receiver, a radio-frequency (RF) heater, a resistive heater, and combinations thereof.
- RF radio-frequency
- the at-least-one tine (e.g., 248 ) includes a component 250 chosen from the group consisting of an electrode, a thermistor, a thermocouple, an acoustic reflector, an acoustic absorber, an acoustic emitter, an acoustic receiver, a radio-frequency (RE) heater, a resistive heater, and combinations thereof.
- a component 250 chosen from the group consisting of an electrode, a thermistor, a thermocouple, an acoustic reflector, an acoustic absorber, an acoustic emitter, an acoustic receiver, a radio-frequency (RE) heater, a resistive heater, and combinations thereof.
- RE radio-frequency
- the exterior surface 228 is like the exterior surface 128 of a previously-illustrated and described construction of the embodiment of FIGS. 1-2 including at least one balloon portion which is expandable and contractible, and which is expandable against patient tissue to provide at least some stabilization of the ultrasound end effector with respect to patient tissue.
- the ultrasound medical system 210 also includes, like a previously-illustrated and described implementation of the embodiment of FIGS.
- a handpiece operatively connected to the ultrasound end effector, wherein the ultrasound end effector has a longitudinal axis and a shaft, wherein the medical ultrasound transducer assembly is supported by the shaft, and wherein the shaft is rotatable with respect to the handpiece about the longitudinal axis.
- Step a) includes obtaining the ultrasound medical system 210 .
- Step b) includes inserting the ultrasound end effector 226 into patient tissue.
- Step c) includes deploying the plurality of tines 246 and 248 to extend sway from the exterior surface 228 into the patient tissue.
- Step d) includes ultrasonically ablating the lesion using the at-least-one medical-treatment ultrasound transducer 220 .
- Step e) includes retrieving the plurality of tines 246 and 248 to retract back toward the exterior surface and storing the plurality of tines 246 and 248 inside the exterior surface 228 .
- Step f) includes withdrawing the ultrasound end effector 226 from the patient tissue.
- Another method also includes the step of employing the plurality of tines 246 and 248 to each act as the element or using each component 250 .
- An additional method also includes the step of expanding the at-least-one balloon portion against patient tissue and contracting the at-least-one balloon portion.
- a third embodiment of the present invention is an ultrasound medical system 310 comprising an ultrasound end effector 326 including a shaft 338 , a sheath 334 , and a medical ultrasound transducer assembly 318 .
- the medical ultrasound transducer assembly 318 is supported by the shaft 338 and has at least one medical-treatment ultrasound transducer 320 .
- the sheath 334 surrounds the shaft 338 .
- the sheath 334 includes at least one balloon portion 330 and 332 which is expandable against patient tissue to provide at least some stabilization of the ultrasound end effector 326 with respect to patient tissue.
- the ultrasound end effector 326 is insertable into a patient.
- the ultrasound end effector 326 is an ultrasound interstitial end effector which is interstitially insertable into patient tissue.
- the ultrasound end effector is insertable into a patient in an endoscopic, laparoscopic, and/or open surgical manner.
- the ultrasound end effector is disposable on the outside of a patient. Other examples and variations are left to the artisan.
- the ultrasound end effector 326 has a longitudinal axis 324 , and the at-least-one balloon portion (e.g., 330 ) acts as an acoustic window and is disposed to longitudinally overlap the at-least-one medical-treatment ultrasound transducer 320 .
- the at-least-one balloon portion e.g., 330
- the at-least-one balloon portion includes at least one through hole 352 .
- the at-least-one balloon portion (e.g., 330 ) includes a plurality of through holes 352 creating a “weeping” balloon portion, wherein some of the acoustic coupling medium inside the sheath 334 extends and/or flows outside the sheath acoustic window providing improved acoustic coupling between the at-least-one medical-treatment ultrasound transducer 320 and patient tissue.
- the at-least-one balloon portion (e.g., 330 ) includes at least one through hole 352 and the ultrasound end effector 326 is adapted to dispense a drug 354 through the at-least-one through hole 352 to patient tissue.
- the drug 354 is carried in a liquid acoustic coupling medium 356 , such as water, disposed between the medical ultrasound transducer assembly 318 and the at-least-one balloon portion 330 whose pressure is controlled (such as by a pump in a handpiece operatively connected to the ultrasound end effector) to expand and contract the at-least-one balloon portion 330 .
- the drug 354 is at least potentiated (i.e., has its medical effect increased and/or activated) by ultrasound emitted from the at-least-one medical-treatment ultrasound transducer 320 .
- the ultrasound end effector 326 has a longitudinal axis 324 , and the at-least-one balloon portion (e.g., 332 ) is disposed longitudinally apart from the at-least-one medical-treatment ultrasound transducer 320 .
- the at-least-one balloon portion e.g., 330
- the at-least-one balloon portion is a blister balloon portion.
- the at-least-one balloon portion is a blister balloon portion.
- the at-least-one balloon portion 330 and 332 includes an outside surface 358 having a roughness average at least equal to 0.005-inch.
- the outside surface includes ribs. Such surface roughness improves stabilization of the ultrasound end effector 326 with respect to patient tissue when the at-least-one balloon portion 330 and 332 is expanded against the patient tissue.
- the ultrasound medical system 310 also includes a controller, like the controller of the previously-illustrated and described arrangement of the embodiment of FIGS.
- the controller is operatively connected to the medical ultrasound transducer assembly, wherein the medical ultrasound transducer assembly is a medical-imaging-and-treatment ultrasound transducer assembly, and wherein the controller determines if the at-least-one balloon portion is acoustically coupled to, or acoustically decoupled from, patient tissue from ultrasonically imaging a balloon-tissue area using the medical-imaging-and-treatment ultrasound transducer assembly.
- Step a) is labeled as “Obtain Interstitial End Effector” in block 460 of FIG. 5 .
- Step a) includes obtaining an interstitial end effector 426 including a distal end 462 and including a medical ultrasound transducer assembly 418 having at least one medical-treatment ultrasound transducer 420 and at least one end-effector-tissue-track ablation device 472 , 474 and 476 .
- Step b) is labeled as “Insert End Effector Into Patient” in block 464 of FIG. 5 .
- Step b) includes inserting the interstitial end effector 426 into the patient creating a tissue track which is surrounded by patient tissue and which ends at the distal end 462 of the inserted interstitial end effector 426 .
- Step c) is labeled as “Ablate Lesion Using Ultrasound” in block 466 of FIG. 5 .
- Step c) includes ultrasonically ablating the lesion using the at-least-one medical-treatment ultrasound transducer 420 .
- Step d) is labeled as “Ablate Tissue Track Using End Effector” in block 468 of FIG. 5 .
- Step d) includes using the at-least-one end-effector-tissue-track ablation device 472 , 474 and 476 to ablate the patient tissue surrounding the tissue track along substantially the entire tissue track.
- Step e) is labeled as “Withdraw End Effector” in block 470 of FIG. 5 .
- Step e) includes withdrawing the interstitial end effector 426 from the patient.
- interstitial end effector 426 is interstitially inserted into patient tissue. It is also noted that the interstitial end effector 426 can be equipped with a retractable tip shield (not shown) for initial endoscopic or laparoscopic patient entry followed by interstitial insertion into patient tissue.
- the step of using the at-least-one end-effector-tissue-track ablation device e.g., 474 .
- the at-least-one end-effector-tissue-track ablation device (e.g., 474 ) includes a non-ultrasound energy source, and step d) uses the non-ultrasound energy source to ablate the patient tissue surrounding the tissue track.
- the non-ultrasound energy source is chosen from the group consisting of a resistive heat energy source, a hot liquid energy source, a monopolar radio-frequency (RF) energy source, a bipolar radio-frequency (RE) energy source, a capacitive heat energy source, a microwave energy source, and combinations thereof.
- the at-least-one end-effector-tissue-track ablation device (e.g., 476 ) includes a tissue-ablating chemical agent, and step d) uses the tissue-ablating chemical agent to ablate the patient tissue surrounding the tissue track.
- the tissue-ablating chemical agent is chosen from the group consisting of fibrin, alcohol, an acidic fluid, a chemotherapeutic agent, and combinations thereof.
- step d) uses the medical ultrasound transducer assembly 418 to ultrasonically ablate the patient tissue surrounding the tissue track.
- step d) ultrasonically ablates at a higher ultrasound frequency than does step c).
- the step of monitoring (such as for acoustic coupling and/or for tissue ablation) the patient tissue surrounding the tissue track during step d).
- the monitoring is chosen from the group consisting of B-mode ultrasonic image monitoring, tissue temperature monitoring, tissue electric impedance, and combinations thereof.
- step b) and before step c) the step of stabilizing (such as by using a balloon, a tine and/or suction) the interstitial end effector 426 with respect to the patient tissue surrounding the tissue track and, after step c) and before step d), the step of releasing the stabilizing of the interstitial end effector 426 with respect to the patient tissue surrounding the tissue track.
- step e) includes stepwise withdrawing the interstitial end effector 426 from the patient using a plurality of positional steps
- step d) includes ablating the patient tissue surrounding the tissue track for a predetermined time with the interstitial end effector at each positional step.
- a fourth embodiment of the present invention is an ultrasound medical system 410 comprising an interstitial end effector 426 which is interstitially insertable into patient tissue, which includes at least one medical-treatment ultrasound transducer 420 , and which includes at least one end-effector-tissue-track ablation device 472 , 474 and 476 .
- the ultrasound medical system 410 includes a controller (such as the controller 142 illustrated in FIG. 1 ) which is operatively connected to the at-least-one medical-treatment ultrasound transducer 420 to ultrasonically ablate a lesion in patient tissue of the patient and which is operatively connected to the at-least-one end-effector-tissue-track ablation device 472 , 474 and 476 to ablate patient tissue surrounding the interstitial end effector 426 during withdrawal of the interstitial end effector 426 from the patient.
- a controller such as the controller 142 illustrated in FIG. 1
- the at-least-one medical-treatment ultrasound transducer 420 to ultrasonically ablate a lesion in patient tissue of the patient
- the at-least-one end-effector-tissue-track ablation device 472 , 474 and 476 to ablate patient tissue surrounding the interstitial end effector 426 during withdrawal of the interstitial end effector 426 from the patient.
- the at-least-one end-effector-tissue-track ablation device 472 , 474 , 476 includes a cylindrical ultrasound transducer 472 .
- the at-least-one end-effector-tissue-track ablation device and the at-least-one medical-treatment ultrasound transducer are a single rotatable ultrasound transducer (such as ultrasound transducer 420 made rotatable such as in a previously illustrated and described implementation of the embodiment of FIGS. 1-2 ).
- Other applications of an end-effector-tissue-track ablation device involving ultrasound are left to the artisan.
- the at-least-one end-effector-tissue-track ablation device 472 , 474 and 476 includes a device 474 which uses a non-ultrasound energy source.
- the non-ultrasound energy source is chosen from the group consisting of a resistive heat energy source, a hot liquid energy source, a monopolar radio-frequency (RF) energy source, a bipolar radio-frequency (RF) energy source, a capacitive heat energy source, a microwave energy source, and combinations thereof.
- the at-least-one end-effector-tissue-track ablation device 472 , 474 and 476 includes a device 476 which releases a tissue-ablating chemical agent.
- the tissue-ablating chemical agent is chosen from the group consisting of fibrin, alcohol, an acidic fluid, a chemotherapeutic agent, and combinations thereof.
- the interstitial end effector 426 has a length and an exterior surface 428 and includes position markings 478 on the exterior surface 428 along at least a portion of its length. Such position markings allow a user to withdraw the interstitial end effector 426 from patient tissue in positional steps while ablating patient tissue surrounding the end-effector tissue track for a predetermined dwell time at each positional step.
- the interstitial end effector 426 has a longitudinal axis 424 and a distal end 462 , and wherein the at-least-one end-effector-tissue-track ablation device 472 , 474 and 476 includes an end-effector-tissue-track ablation device (such as 474 ) which is disposed proximate the distal end 462 .
- the distal end of an interstitial end effector is an end having a tissue-piercing tip.
- the interstitial end effector 426 includes a tissue-ablating component (such as 474 ) adapted (such as by having a resistive heat energy source) to ablate (such as to thermally ablate) patient tissue longitudinally forward of the distal end 462 .
- a tissue-ablating component such as 474
- ablate such as to thermally ablate
- the ultrasound interstitial end effector includes a sheath 434 surrounding the medical-treatment ultrasound transducer 120 and having an acoustic window 480 .
- the entire sheath acts as an acoustic window.
- the acoustic window is a thinner portion of the sheath.
- the acoustic window is a separate material(s) from the material(s) of the non-acoustic-window portion(s) of the sheath. Acoustic window component materials are known to those skilled in the art. Other modifications are left to the artisan.
- having an interstitial end effector with a medical-treatment ultrasound transducer and an end-effector-tissue-track ablation device allows ultrasonic ablation of a lesion using the medical-treatment ultrasound transducer and allows ablation of patient tissue surrounding the tissue track as the interstitial end effector is withdrawn from the patient to help reduce the possibility of excessive bleeding and/or tissue contamination.
Abstract
An ultrasound medical system includes an interstitial end effector. The interstitial end effector is interstitially insertable into patient tissue, includes at least one medical-treatment ultrasound transducer, and includes at least one end-effector-tissue-track ablation device. One method for ultrasonically treating a lesion in a patient includes the steps of obtaining the interstitial end effector and inserting it into the patient creating a tissue track which is surrounded by patient tissue and which ends at the distal end of the inserted interstitial end effector. Other steps include ultrasonically ablating the lesion using the at-least-one medical-treatment ultrasound transducer, using the at-least-one end-effector-tissue-track ablation device to ablate the patient tissue surrounding the tissue track along substantially the entire tissue track, and withdrawing the end effector from the patient.
Description
- The present application is a continuation application of U.S. patent application Ser. No. 12/145,635, filed on Jun. 25, 2008. The present application claims all the benefit of and priority to U.S. patent application Ser. No. 12/145,635, filed on Jun. 25, 2008, which is a divisional application of U.S. patent application Ser. No. 10/850,984, filed on May 21, 2004, which issued as U.S. Pat. No. 7,473,250, all of which are incorporate by reference herein.
- The present invention relates generally to ultrasound, and more particularly to ultrasound medical systems and methods.
- Known medical methods include using ultrasound imaging (at low power) of patients to identify patient tissue for medical treatment and include using ultrasound (at high power) to ablate identified patient tissue by heating the tissue.
- Known ultrasound medical systems and methods include deploying an ultrasound end effector having an ultrasound transducer outside the body to break up kidney stones inside the body, endoscopically inserting an ultrasound end effector having an ultrasound transducer in the rectum to medically destroy prostate cancer, laparoscopically inserting an ultrasound end effector having an ultrasound transducer in the abdominal cavity to medically destroy a cancerous liver tumor, intravenously inserting a catheter ultrasound end effector having an ultrasound transducer into a vein in the arm and moving the catheter to the heart to medically destroy diseased heart tissue, and interstitially inserting a needle ultrasound end effector having an ultrasound transducer needle into the tongue to medically destroy tissue to reduce tongue volume to reduce snoring.
- Rotatable ultrasound end effectors are known wherein an ultrasound transducer is non-rotatably attached to a shaft whose distal end is circumferentially and longitudinally surrounded by a sheath having a longitudinal axis and having an acoustic window. Water between the shaft and the sheath provides acoustic coupling between the ultrasound transducer and the acoustic window. The shaft is rotatable about the longitudinal axis with respect to the sheath. The sheath is non-rotatably attached to a handpiece.
- Known medical systems and methods include deploying a radio-frequency (RF) end effector having an RF electrode to thermally ablate patient tissue and to take tissue electric impedance and tissue temperature measurements using electrodes integrated into the shaft or into a tine which also helps stabilize the RF end effector in patient tissue.
- Still, scientists and engineers continue to seek improved ultrasound medical systems and methods.
- A method of the invention is for ultrasonically treating a lesion in a patient and includes steps a) through e). Step a) includes obtaining an interstitial end effector having a distal end, including a medical ultrasound transducer assembly having at least one medical-treatment ultrasound transducer, and including at least one end-effector-tissue-track ablation device. Step b) includes inserting the interstitial end effector into the patient creating a tissue track which is surrounded by patient tissue and which ends at the distal end of the inserted interstitial end effector. Step c) includes ultrasonically ablating the lesion using the at-least-one medical-treatment ultrasound transducer. Step d) includes using the at-least-one end-effector-tissue-track ablation device to ablate the patient tissue surrounding the tissue track along substantially the entire tissue track. Step e) includes withdrawing the end effector from the patient.
- An embodiment of the invention is an ultrasound medical system including an interstitial end effector. The interstitial end effector is interstitially insertable into patient tissue, includes at least one medical-treatment ultrasound transducer, and includes at least one end-effector-tissue-track ablation device.
- Several benefits and advantages are obtained from one or more of the embodiments and methods of the invention. In one example, having an interstitial end effector with a medical-treatment ultrasound transducer and an end-effector-tissue-track ablation device allows ultrasonic ablation of a lesion using the medical-treatment ultrasound transducer and allows ablation of patient tissue surrounding the tissue track as the interstitial end effector is withdrawn from the patient to help reduce the possibility of excessive bleeding and/or tissue contamination.
- The present invention has, without limitation, application in conventional interstitial, endoscopic, laparoscopic, and open surgical instrumentation as well as application in robotic-assisted surgery.
-
FIG. 1 is a perspective view of a first embodiment of the present invention showing an ultrasound medical system which includes an end effector, a handpiece, and a controller; -
FIG. 2 is a schematic cross-sectional view of a first embodiment of the end effector and the handpiece of the ultrasound medical system ofFIG. 1 showing a medical ultrasound transducer assembly and two non-ultrasound tissue-property-measuring sensors; -
FIG. 3 is a view, as inFIG. 2 , but of a second embodiment of a handpiece and of an end effector having a medical ultrasound transducer assembly and two tines; -
FIG. 4 is a view, as inFIG. 2 , but of a third embodiment of an end effector having a medical ultrasound transducer assembly supported by a shaft and having a surrounding sheath, wherein the sheath includes two balloon portions; -
FIG. 5 is a block diagram view of a method of the invention for ultrasonically treating a lesion in a patient; and -
FIG. 6 is a schematic view, partially in cross-section, of a fourth embodiment of an end effector which has a medical-treatment ultrasound transducer and three end-effector-tissue-track ablation devices and which can be used in one employment of the method ofFIG. 5 . - Before explaining the present invention in detail, it should be noted that the invention is not limited in its application or use to the details of construction and arrangement of parts and/or steps illustrated in the accompanying drawings and description. The illustrative embodiments and methods of the invention may be implemented or incorporated in other embodiments, methods, variations and modifications, and may be practiced or carried out in various ways. Furthermore, unless otherwise indicated, the terms and expressions employed herein have been chosen for the purpose of describing the illustrative embodiments and methods of the present invention for the convenience of the reader and are not for the purpose of limiting the invention.
- It is understood that any one or more of the following-described embodiments, methods, examples, etc, can be combined with any one or more of the other following-described embodiments, methods, examples, etc.
- Referring now to
FIGS. 1-2 of the drawings, a first embodiment of the present invention is an ultrasoundmedical system 110 comprising anultrasound end effector 112 and at least one non-ultrasound tissue-property-measuring sensor ultrasound end effector 112 includes a medicalultrasound transducer assembly 118 having at least one medical-treatment ultrasound transducer 120. The at-least-one non-ultrasound tissue-property-measuring sensor ultrasound end effector 112 and is disposable in contact withpatient tissue 122. - It is noted that a medical-treatment ultrasound transducer includes a medical-treatment-only ultrasound transducer and a medical-imaging-and-treatment ultrasound transducer. In one arrangement, an ultrasound transducer has a single transducer element, and in another arrangement, an ultrasound transducer has a plurality (also called an array) of transducer elements. It is also noted that a medical ultrasound transducer assembly having at least one medical-treatment ultrasound transducer can also have at least one medical-imaging ultrasound transducer.
- In one example of the embodiment of
FIGS. 1-2 , theultrasound end effector 112 includes alongitudinal axis 124. In this example, the at-least-one non-ultrasound tissue-property-measuring sensor measuring sensor 114 and a second non-ultrasound tissue-property-measuring sensor 116. The at-least-one medical-treatment ultrasound transducer 120 is disposed longitudinally between the first and second non-ultrasound tissue-property-measuring sensors - In one variation of the embodiment of
FIGS. 1-2 , the at-least-one non-ultrasound tissue-property-measuring sensor (e.g., 114) measures tissue temperature. In one modification, the at-least-one non-ultrasound tissue-property-measuring sensor (e.g., 114) is chosen from the group consisting of a thermistor, a thermocouple, and combinations thereof. In another variation, the at-least-one non-ultrasound tissue-property-measuring sensor (e.g., 116) measures tissue electric impedance. In one modification, the at-least-one non-ultrasound tissue-property-measuring sensor (e.g., 116) is chosen from the group consisting of a monopolar electrode, a bipolar electrode, and combinations thereof. It is noted that tissue temperature and/or tissue electric impedance is a measure of the degree of ultrasonic ablation of patient tissue, as can be appreciated by those skilled in the art. - In one construction of the embodiment of
FIGS. 1-2 , theultrasound end effector 112 is an ultrasoundinterstitial end effector 126 which is interstitially insertable intopatient tissue 122 and which has anexterior surface 128. The at-least-one non-ultrasound tissue-property-measuring sensor interstitial end effector 126 and is fixedly disposed substantially flush with theexterior surface 128. In one arrangement, theexterior surface 128 includes at least oneballoon portion patient tissue 122 to provide at least some stabilization of the ultrasoundinterstitial end effector 126 with respect topatient tissue 122. In one variation, theexterior surface 128 is the exterior surface of asheath 134 and has first andsecond balloon portions first balloon portion 130 surrounds the medicalultrasound transducer assembly 118 and acts as an acoustic window, and wherein thesecond balloon portion 132 is longitudinally spaced apart from the medicalultrasound transducer assembly 118. An acoustic coupling medium, such as water, is disposable between the medicalultrasound transducer assembly 118 and thefirst balloon portion 130 and has been omitted fromFIG. 2 for clarity. In one modification, thefirst balloon portion 130 is omitted and thesheath 134 terminates before the medicalultrasound transducer assembly 118 which is exposed to patient tissue. In another modification, thesecond balloon portion 132 is omitted. In one employment, the at-least-oneballoon portion interstitial end effector 126. Other constructions, arrangements, variations, and modifications are left to the artisan. - In one enablement of the embodiment of
FIGS. 1-2 , theultrasound end effector 112 is an ultrasoundinterstitial end effector 126 which is interstitially insertable intopatient tissue 122 and which has anexterior surface 128. In this enablement, the at least-one non-ultrasound tissue-property-measuringsensor patient tissue 128 to provide at least some stabilization of the ultrasoundinterstitial end effector 126 with respect topatient tissue 122 and is retrievable to retract back toward theexterior surface 128. In one arrangement, the at-least-one non-ultrasound tissue-property-measuringsensor - In one implementation of the embodiment of
FIGS. 1-2 , the ultrasoundmedical system 110 also includes ahandpiece 136 operatively connected to theultrasound end effector 112. Theultrasound end effector 112 has alongitudinal axis 124 and ashaft 138, and the medicalultrasound transducer assembly 118 is supported by theshaft 138. Theshaft 138 is rotatable with respect to thehandpiece 136 about thelongitudinal axis 124 and is supported bybearings 139. In one variation, amotor 140 rotates theshaft 138. In one arrangement, the ultrasoundmedical system 110 includes acontroller 142 operatively connected to thehandpiece 136 via acable 144. - A second embodiment of the present invention, shown in
FIG. 3 , is an ultrasoundmedical system 210 comprising anultrasound end effector 226. Theultrasound end effector 226 has anexterior surface 228. Theultrasound end effector 226 includes a medicalultrasound transducer assembly 218 having at least one medical-treatment ultrasound transducer 220, and includes at least onetine tine ultrasound end effector 226 with respect to patient tissue and is retrievable to retract back toward theexterior surface 228. - In one example of the embodiment of
FIG. 3 , theultrasound end effector 226 is insertable into a patient. In one variation, theultrasound end effector 226 is an ultrasound interstitial end effector which is interstitially insertable into patient tissue. In other variations, the ultrasound end effector is insertable into a patient in an endoscopic, laparoscopic, and/or open surgical manner. In another example, the ultrasound end effector is disposable on the outside of a patient. Other examples and variations are left to the artisan. - In one enablement of the embodiment of
FIG. 3 , the at-least-onetine FIG. 3 , the at-least-onetine deployable tines ultrasound end effector 226 is within the level of skill of the artisan. In one arrangement, such deployment is accomplished using one or more of cables, levers,motors 249, gearing, push rods and the like to move a tine partially out of, and back into, a lumen in the end effector. In one choice of materials, the tine comprises or consists essentially of Nitinol wire or nichrome wire. - In one employment of the embodiment of
FIG. 3 , the at-least-one tine (e.g., 246) acts as an element chosen from the group consisting of an electrode, a thermistor, a thermocouple, an acoustic reflector, an acoustic absorber, an acoustic emitter, an acoustic receiver, a radio-frequency (RF) heater, a resistive heater, and combinations thereof. In another employment, the at-least-one tine (e.g., 248) includes acomponent 250 chosen from the group consisting of an electrode, a thermistor, a thermocouple, an acoustic reflector, an acoustic absorber, an acoustic emitter, an acoustic receiver, a radio-frequency (RE) heater, a resistive heater, and combinations thereof. - The embodiment, examples, constructions, implementations, etc. of the embodiment of
FIGS. 1-2 are equally applicable to the embodiment, constructions, implementations, etc. ofFIG. 3 . In one construction of the embodiment ofFIG. 3 , theexterior surface 228 is like theexterior surface 128 of a previously-illustrated and described construction of the embodiment ofFIGS. 1-2 including at least one balloon portion which is expandable and contractible, and which is expandable against patient tissue to provide at least some stabilization of the ultrasound end effector with respect to patient tissue. In one implementation of the embodiment ofFIG. 3 , the ultrasoundmedical system 210 also includes, like a previously-illustrated and described implementation of the embodiment ofFIGS. 1-2 , a handpiece operatively connected to the ultrasound end effector, wherein the ultrasound end effector has a longitudinal axis and a shaft, wherein the medical ultrasound transducer assembly is supported by the shaft, and wherein the shaft is rotatable with respect to the handpiece about the longitudinal axis. - One method, using the embodiment of
FIG. 3 and enablements, examples, employments, and constructions thereof, is for ultrasonically treating a lesion in a patient and includes steps a) through f), Step a) includes obtaining the ultrasoundmedical system 210. Step b) includes inserting theultrasound end effector 226 into patient tissue. Step c) includes deploying the plurality oftines exterior surface 228 into the patient tissue. Step d) includes ultrasonically ablating the lesion using the at-least-one medical-treatment ultrasound transducer 220. Step e) includes retrieving the plurality oftines tines exterior surface 228. Step f) includes withdrawing theultrasound end effector 226 from the patient tissue. Another method also includes the step of employing the plurality oftines component 250. An additional method also includes the step of expanding the at-least-one balloon portion against patient tissue and contracting the at-least-one balloon portion. - A third embodiment of the present invention, shown in
FIG. 4 , is an ultrasoundmedical system 310 comprising anultrasound end effector 326 including ashaft 338, asheath 334, and a medicalultrasound transducer assembly 318. The medicalultrasound transducer assembly 318 is supported by theshaft 338 and has at least one medical-treatment ultrasound transducer 320. Thesheath 334 surrounds theshaft 338. Thesheath 334 includes at least oneballoon portion ultrasound end effector 326 with respect to patient tissue. - In one example of the embodiment of
FIG. 4 , theultrasound end effector 326 is insertable into a patient. In one variation, theultrasound end effector 326 is an ultrasound interstitial end effector which is interstitially insertable into patient tissue. In other variations, the ultrasound end effector is insertable into a patient in an endoscopic, laparoscopic, and/or open surgical manner. In another example, the ultrasound end effector is disposable on the outside of a patient. Other examples and variations are left to the artisan. - In one construction of the embodiment of
FIG. 3 , theultrasound end effector 326 has alongitudinal axis 324, and the at-least-one balloon portion (e.g., 330) acts as an acoustic window and is disposed to longitudinally overlap the at-least-one medical-treatment ultrasound transducer 320. In one variation of this construction, the at-least-one balloon portion (e.g., 330) includes at least one throughhole 352. In one modification, the at-least-one balloon portion (e.g., 330) includes a plurality of throughholes 352 creating a “weeping” balloon portion, wherein some of the acoustic coupling medium inside thesheath 334 extends and/or flows outside the sheath acoustic window providing improved acoustic coupling between the at-least-one medical-treatment ultrasound transducer 320 and patient tissue. - In one arrangement of the embodiment of
FIG. 3 , the at-least-one balloon portion (e.g., 330) includes at least one throughhole 352 and theultrasound end effector 326 is adapted to dispense adrug 354 through the at-least-one throughhole 352 to patient tissue. In one variation, thedrug 354 is carried in a liquidacoustic coupling medium 356, such as water, disposed between the medicalultrasound transducer assembly 318 and the at-least-oneballoon portion 330 whose pressure is controlled (such as by a pump in a handpiece operatively connected to the ultrasound end effector) to expand and contract the at-least-oneballoon portion 330. In one variation, thedrug 354 is at least potentiated (i.e., has its medical effect increased and/or activated) by ultrasound emitted from the at-least-one medical-treatment ultrasound transducer 320. - In the same or another arrangement of the embodiment of
FIG. 3 , theultrasound end effector 326 has alongitudinal axis 324, and the at-least-one balloon portion (e.g., 332) is disposed longitudinally apart from the at-least-one medical-treatment ultrasound transducer 320. In one variation of the embodiment ofFIG. 3 , the at-least-one balloon portion (e.g., 330) is a fully-circumferential balloon portion. In a different variation, the at-least-one balloon portion (e.g., 332) is a blister balloon portion. In one example of the embodiment ofFIG. 3 , the at-least-oneballoon portion outside surface 358 having a roughness average at least equal to 0.005-inch. In one variation, the outside surface includes ribs. Such surface roughness improves stabilization of theultrasound end effector 326 with respect to patient tissue when the at-least-oneballoon portion - The embodiments, constructions, implementations, etc. of the embodiments of
FIGS. 1-2 and 3 are equally applicable to the embodiment, constructions, implementations, etc. of the embodiment ofFIG. 4 . In one implementation of the embodiment ofFIG. 3 , the ultrasoundmedical system 310 also includes a controller, like the controller of the previously-illustrated and described arrangement of the embodiment ofFIGS. 1-2 , wherein the controller is operatively connected to the medical ultrasound transducer assembly, wherein the medical ultrasound transducer assembly is a medical-imaging-and-treatment ultrasound transducer assembly, and wherein the controller determines if the at-least-one balloon portion is acoustically coupled to, or acoustically decoupled from, patient tissue from ultrasonically imaging a balloon-tissue area using the medical-imaging-and-treatment ultrasound transducer assembly. - One method of the invention for ultrasonically treating a lesion in a patient is shown in block diagram form in
FIG. 5 , and an embodiment of an ultrasound medical system which can be used in performing the method is shown inFIG. 6 . The method includes steps a) through e). Step a) is labeled as “Obtain Interstitial End Effector” inblock 460 ofFIG. 5 . Step a) includes obtaining aninterstitial end effector 426 including adistal end 462 and including a medicalultrasound transducer assembly 418 having at least one medical-treatment ultrasound transducer 420 and at least one end-effector-tissue-track ablation device block 464 ofFIG. 5 . Step b) includes inserting theinterstitial end effector 426 into the patient creating a tissue track which is surrounded by patient tissue and which ends at thedistal end 462 of the insertedinterstitial end effector 426. Step c) is labeled as “Ablate Lesion Using Ultrasound” inblock 466 ofFIG. 5 . Step c) includes ultrasonically ablating the lesion using the at-least-one medical-treatment ultrasound transducer 420. Step d) is labeled as “Ablate Tissue Track Using End Effector” in block 468 ofFIG. 5 . Step d) includes using the at-least-one end-effector-tissue-track ablation device block 470 ofFIG. 5 . Step e) includes withdrawing theinterstitial end effector 426 from the patient. - It is noted that creating a tissue track requires that the
interstitial end effector 426 be interstitially inserted into patient tissue. It is also noted that theinterstitial end effector 426 can be equipped with a retractable tip shield (not shown) for initial endoscopic or laparoscopic patient entry followed by interstitial insertion into patient tissue. - In one extension of the method of
FIG. 5 , there is included the step of using the at-least-one end-effector-tissue-track ablation device (e.g., 474) to ablate the patient tissue at thedistal end 462 of the insertedinterstitial end effector 426. - In one implementation of the method of
FIG. 5 , the at-least-one end-effector-tissue-track ablation device (e.g., 474) includes a non-ultrasound energy source, and step d) uses the non-ultrasound energy source to ablate the patient tissue surrounding the tissue track. In one variation, the non-ultrasound energy source is chosen from the group consisting of a resistive heat energy source, a hot liquid energy source, a monopolar radio-frequency (RF) energy source, a bipolar radio-frequency (RE) energy source, a capacitive heat energy source, a microwave energy source, and combinations thereof. - in another implementation of the method, the at-least-one end-effector-tissue-track ablation device (e.g., 476) includes a tissue-ablating chemical agent, and step d) uses the tissue-ablating chemical agent to ablate the patient tissue surrounding the tissue track. In one variation, the tissue-ablating chemical agent is chosen from the group consisting of fibrin, alcohol, an acidic fluid, a chemotherapeutic agent, and combinations thereof.
- In a further implementation of the method, step d) uses the medical
ultrasound transducer assembly 418 to ultrasonically ablate the patient tissue surrounding the tissue track. In one variation, step d) ultrasonically ablates at a higher ultrasound frequency than does step c). - In the same or another extension of the method of
FIG. 5 , there is included the step of monitoring (such as for acoustic coupling and/or for tissue ablation) the patient tissue surrounding the tissue track during step d). In one variation, the monitoring is chosen from the group consisting of B-mode ultrasonic image monitoring, tissue temperature monitoring, tissue electric impedance, and combinations thereof. - In the same or another extension of the method of
FIG. 5 , there are included, after step b) and before step c), the step of stabilizing (such as by using a balloon, a tine and/or suction) theinterstitial end effector 426 with respect to the patient tissue surrounding the tissue track and, after step c) and before step d), the step of releasing the stabilizing of theinterstitial end effector 426 with respect to the patient tissue surrounding the tissue track. - In one application of the method of
FIG. 5 , step e) includes stepwise withdrawing theinterstitial end effector 426 from the patient using a plurality of positional steps, and step d) includes ablating the patient tissue surrounding the tissue track for a predetermined time with the interstitial end effector at each positional step. - A fourth embodiment of the present invention, shown in
FIG. 6 , is an ultrasoundmedical system 410 comprising aninterstitial end effector 426 which is interstitially insertable into patient tissue, which includes at least one medical-treatment ultrasound transducer 420, and which includes at least one end-effector-tissue-track ablation device - In one enablement of the embodiment of
FIG. 6 , the ultrasoundmedical system 410 includes a controller (such as thecontroller 142 illustrated inFIG. 1 ) which is operatively connected to the at-least-one medical-treatment ultrasound transducer 420 to ultrasonically ablate a lesion in patient tissue of the patient and which is operatively connected to the at-least-one end-effector-tissue-track ablation device interstitial end effector 426 during withdrawal of theinterstitial end effector 426 from the patient. - In one application of the embodiment of
FIG. 6 , the at-least-one end-effector-tissue-track ablation device cylindrical ultrasound transducer 472. In the same or a different application, the at-least-one end-effector-tissue-track ablation device and the at-least-one medical-treatment ultrasound transducer are a single rotatable ultrasound transducer (such asultrasound transducer 420 made rotatable such as in a previously illustrated and described implementation of the embodiment ofFIGS. 1-2 ). Other applications of an end-effector-tissue-track ablation device involving ultrasound are left to the artisan. - In another application of the embodiment of
FIG. 6 , the at-least-one end-effector-tissue-track ablation device device 474 which uses a non-ultrasound energy source. In one variation, the non-ultrasound energy source is chosen from the group consisting of a resistive heat energy source, a hot liquid energy source, a monopolar radio-frequency (RF) energy source, a bipolar radio-frequency (RF) energy source, a capacitive heat energy source, a microwave energy source, and combinations thereof. - In a further application of the embodiment of
FIG. 6 , the at-least-one end-effector-tissue-track ablation device device 476 which releases a tissue-ablating chemical agent. In one variation, the tissue-ablating chemical agent is chosen from the group consisting of fibrin, alcohol, an acidic fluid, a chemotherapeutic agent, and combinations thereof. - In one construction of the embodiment of
FIG. 6 , theinterstitial end effector 426 has a length and anexterior surface 428 and includesposition markings 478 on theexterior surface 428 along at least a portion of its length. Such position markings allow a user to withdraw theinterstitial end effector 426 from patient tissue in positional steps while ablating patient tissue surrounding the end-effector tissue track for a predetermined dwell time at each positional step. In the same or a different construction, theinterstitial end effector 426 has a longitudinal axis 424 and adistal end 462, and wherein the at-least-one end-effector-tissue-track ablation device distal end 462. It is noted that the distal end of an interstitial end effector is an end having a tissue-piercing tip. In the same or a different construction, theinterstitial end effector 426 includes a tissue-ablating component (such as 474) adapted (such as by having a resistive heat energy source) to ablate (such as to thermally ablate) patient tissue longitudinally forward of thedistal end 462. - In one variation, the ultrasound interstitial end effector includes a
sheath 434 surrounding the medical-treatment ultrasound transducer 120 and having anacoustic window 480. In one modification, the entire sheath acts as an acoustic window. In another modification, the acoustic window is a thinner portion of the sheath. In a further modification, the acoustic window is a separate material(s) from the material(s) of the non-acoustic-window portion(s) of the sheath. Acoustic window component materials are known to those skilled in the art. Other modifications are left to the artisan. - It is noted that the embodiments, constructions, implementations, etc. of the embodiments of
FIGS. 1-2 , 3 and 4 are equally applicable to the embodiment, constructions, implementations, etc. of the embodiment ofFIG. 6 . - Several benefits and advantages are obtained from one or more of the embodiments and method of the invention. In one example, having an interstitial end effector with a medical-treatment ultrasound transducer and an end-effector-tissue-track ablation device allows ultrasonic ablation of a lesion using the medical-treatment ultrasound transducer and allows ablation of patient tissue surrounding the tissue track as the interstitial end effector is withdrawn from the patient to help reduce the possibility of excessive bleeding and/or tissue contamination.
- While the present invention has been illustrated by a description of several embodiments and methods, it is not the intention of the applicants to restrict or limit the spirit and scope of the appended claims to such detail. Numerous other variations, changes, and substitutions will occur to those skilled in the art without departing from the scope of the invention. For instance, the ultrasound medical system of the invention has application in robotic assisted surgery taking into account the obvious modifications of such systems, components and methods to be compatible with such a robotic system. It will be understood that the foregoing description is provided by way of example, and that other modifications may occur to those skilled in the art without departing from the scope and spirit of the appended Claims.
Claims (20)
1. An ultrasound treatment system comprising:
a probe comprising a treatment ultrasound transducer configured to treat patient tissue;
a non-ultrasound tissue-property measuring sensor coupled to the probe; and
a controller configured to communicate with the probe and the non-ultrasound tissue-property measuring sensor;
wherein the non-ultrasound tissue-property measuring sensor is positioned to be in contact with the patient tissue
wherein the controller is configured to control the probe and to receive feedback from the non-ultrasound tissue-property measuring sensor.
2. The ultrasound treatment system according to claim 1 , wherein the non-ultrasound tissue-property measuring sensor is configured to measure tissue temperature.
3. The ultrasound treatment system according to claim 2 , wherein the non-ultrasound tissue-property measuring sensor is at least one of a thermistor, and a thermocouple.
4. The ultrasound treatment system according to claim 1 , wherein the non-ultrasound tissue-property measuring sensor is configured to measure tissue electrical impedance.
5. The ultrasound treatment system according to claim 4 , wherein the non-ultrasound tissue-property measuring sensor is at least one of a monopolar electrode, and a bipolar electrode.
6. The ultrasound treatment system according to claim 1 , wherein the non-ultrasound tissue-property measuring sensor is configured to a measure of the degree of ultrasonic ablation of the patient tissue.
7. The ultrasound treatment system according to claim 1 , wherein the non-ultrasound tissue-property measuring sensor is configured to a measure of the degree of acoustic coupling to patient tissue.
8. The ultrasound treatment system according to claim 1 , further comprising a tissue-ablating chemical agent configured to ablate the patient tissue.
9. The ultrasound treatment system according to claim 1 , wherein the tissue-ablating chemical agent is at least one of fibrin, alcohol, an acidic fluid, and a chemotherapeutic agent.
10. The ultrasound treatment system according to claim 1 , further comprising a non-ultrasound energy source configured to ablate the patient tissue.
11. The ultrasound treatment system according to claim 10 , wherein the non-ultrasound energy source is at least one of a resistive heat energy source, a hot liquid energy source, a monopolar radio-frequency energy source, a bipolar radio-frequency energy source, a capacitive heat energy source, and a microwave energy source.
12. The ultrasound treatment system according to claim 1 , wherein the probe is configured to dispense a drug to the patient tissue.
13. The ultrasound treatment system according to claim 12 , wherein the drug is at least potentiated by ultrasound energy emitted from the treatment ultrasound transducer.
14. An ultrasound treatment system comprising:
a hand piece comprising a treatment ultrasound transducer configured to treat patient tissue; and
a non-ultrasound tissue-property measuring sensor configured to measure tissue electrical impedance;
wherein the non-ultrasound tissue-property measuring sensor is positioned to be in contact with the patient tissue
wherein the tissue electrical impedance reported by the sensor is a measure of the degree of ultrasonic ablation of the patient tissue.
15. The ultrasound treatment system according to claim 14 , further comprising a controller configured to control the treatment ultrasound transducer and to receive the tissue electrical impedance reported by the non-ultrasound tissue-property measuring sensor.
16. The ultrasound treatment system according to claim 14 , wherein the non-ultrasound tissue-property measuring sensor is at least one of a monopolar electrode, and a bipolar electrode.
17. The ultrasound treatment system according to claim 14 , further comprising at least one imaging ultrasound transducer positioned in the hand piece.
18. The ultrasound treatment system according to claim 14 , wherein the non-ultrasound tissue-property measuring sensor is configured to monitor the patient tissue during treatment.
19. An ultrasound treatment system comprising:
a hand-held probe comprising at least one ultrasound transducer configured to treat patient tissue; and
a non-ultrasound tissue-property measuring sensor supported by the hand-held probe and positioned to be in contact with the patient tissue, the non-ultrasound tissue-property measuring sensor is configured to measure tissue electrical impedance and to report a measure of measure of the degree of ultrasonic ablation of the patient tissue as a function of the measure tissue electrical impedance.
20. The ultrasound treatment system according to claim 14 , further comprising a controller configured to control the treatment ultrasound transducer and to receive the tissue electrical impedance reported by the non-ultrasound tissue-property measuring sensor.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/752,151 US20130218013A1 (en) | 2004-05-21 | 2013-01-28 | Ultrasound Medical System and Method |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/850,984 US7473250B2 (en) | 2004-05-21 | 2004-05-21 | Ultrasound medical system and method |
US12/145,635 US20080287837A1 (en) | 2004-05-21 | 2008-06-25 | Ultrasound medical system and method |
US13/752,151 US20130218013A1 (en) | 2004-05-21 | 2013-01-28 | Ultrasound Medical System and Method |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/145,635 Continuation US20080287837A1 (en) | 2004-05-21 | 2008-06-25 | Ultrasound medical system and method |
Publications (1)
Publication Number | Publication Date |
---|---|
US20130218013A1 true US20130218013A1 (en) | 2013-08-22 |
Family
ID=35376151
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/850,984 Active 2025-08-09 US7473250B2 (en) | 2004-05-21 | 2004-05-21 | Ultrasound medical system and method |
US12/145,635 Abandoned US20080287837A1 (en) | 2004-05-21 | 2008-06-25 | Ultrasound medical system and method |
US13/752,151 Abandoned US20130218013A1 (en) | 2004-05-21 | 2013-01-28 | Ultrasound Medical System and Method |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/850,984 Active 2025-08-09 US7473250B2 (en) | 2004-05-21 | 2004-05-21 | Ultrasound medical system and method |
US12/145,635 Abandoned US20080287837A1 (en) | 2004-05-21 | 2008-06-25 | Ultrasound medical system and method |
Country Status (1)
Country | Link |
---|---|
US (3) | US7473250B2 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10426429B2 (en) | 2015-10-08 | 2019-10-01 | Decision Sciences Medical Company, LLC | Acoustic orthopedic tracking system and methods |
US10743838B2 (en) | 2015-02-25 | 2020-08-18 | Decision Sciences Medical Company, LLC | Acoustic signal transmission couplants and coupling mediums |
US10993699B2 (en) | 2011-10-28 | 2021-05-04 | Decision Sciences International Corporation | Spread spectrum coded waveforms in ultrasound diagnostics |
US11096661B2 (en) | 2013-09-13 | 2021-08-24 | Decision Sciences International Corporation | Coherent spread-spectrum coded waveforms in synthetic aperture image formation |
US11154274B2 (en) | 2019-04-23 | 2021-10-26 | Decision Sciences Medical Company, LLC | Semi-rigid acoustic coupling articles for ultrasound diagnostic and treatment applications |
US11520043B2 (en) | 2020-11-13 | 2022-12-06 | Decision Sciences Medical Company, LLC | Systems and methods for synthetic aperture ultrasound imaging of an object |
US11957516B2 (en) | 2023-02-27 | 2024-04-16 | Decision Sciences International Corporation | Spread spectrum coded waveforms in ultrasound diagnostics |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7846096B2 (en) | 2001-05-29 | 2010-12-07 | Ethicon Endo-Surgery, Inc. | Method for monitoring of medical treatment using pulse-echo ultrasound |
US20030069502A1 (en) | 2001-05-29 | 2003-04-10 | Makin Inder Raj. S. | Ultrasound feedback in medically-treated patients |
US20050240124A1 (en) * | 2004-04-15 | 2005-10-27 | Mast T D | Ultrasound medical treatment system and method |
US7951095B2 (en) | 2004-05-20 | 2011-05-31 | Ethicon Endo-Surgery, Inc. | Ultrasound medical system |
US7473250B2 (en) * | 2004-05-21 | 2009-01-06 | Ethicon Endo-Surgery, Inc. | Ultrasound medical system and method |
US7806839B2 (en) | 2004-06-14 | 2010-10-05 | Ethicon Endo-Surgery, Inc. | System and method for ultrasound therapy using grating lobes |
US20070016184A1 (en) * | 2005-07-14 | 2007-01-18 | Ethicon Endo-Surgery, Inc. | Medical-treatment electrode assembly and method for medical treatment |
US20070213705A1 (en) * | 2006-03-08 | 2007-09-13 | Schmid Peter M | Insulated needle and system |
US7728868B2 (en) | 2006-08-02 | 2010-06-01 | Inneroptic Technology, Inc. | System and method of providing real-time dynamic imagery of a medical procedure site using multiple modalities |
US20090062724A1 (en) * | 2007-08-31 | 2009-03-05 | Rixen Chen | System and apparatus for sonodynamic therapy |
WO2009094646A2 (en) * | 2008-01-24 | 2009-07-30 | The University Of North Carolina At Chapel Hill | Methods, systems, and computer readable media for image guided ablation |
ES2428719T3 (en) | 2008-03-31 | 2013-11-11 | Applied Medical Resources Corporation | Electrosurgical system with means to measure tissue permittivity and conductivity |
EP2268361B8 (en) * | 2008-04-09 | 2019-05-22 | Julian Itzcovitz | Percutaneous probe |
US8690776B2 (en) | 2009-02-17 | 2014-04-08 | Inneroptic Technology, Inc. | Systems, methods, apparatuses, and computer-readable media for image guided surgery |
US8554307B2 (en) | 2010-04-12 | 2013-10-08 | Inneroptic Technology, Inc. | Image annotation in image-guided medical procedures |
US11464578B2 (en) | 2009-02-17 | 2022-10-11 | Inneroptic Technology, Inc. | Systems, methods, apparatuses, and computer-readable media for image management in image-guided medical procedures |
US8641621B2 (en) | 2009-02-17 | 2014-02-04 | Inneroptic Technology, Inc. | Systems, methods, apparatuses, and computer-readable media for image management in image-guided medical procedures |
US8523852B2 (en) | 2009-04-17 | 2013-09-03 | Domain Surgical, Inc. | Thermally adjustable surgical tool system |
US9107666B2 (en) | 2009-04-17 | 2015-08-18 | Domain Surgical, Inc. | Thermal resecting loop |
US9131977B2 (en) | 2009-04-17 | 2015-09-15 | Domain Surgical, Inc. | Layered ferromagnetic coated conductor thermal surgical tool |
US9078655B2 (en) | 2009-04-17 | 2015-07-14 | Domain Surgical, Inc. | Heated balloon catheter |
US9265556B2 (en) | 2009-04-17 | 2016-02-23 | Domain Surgical, Inc. | Thermally adjustable surgical tool, balloon catheters and sculpting of biologic materials |
JP6143362B2 (en) | 2010-10-01 | 2017-06-07 | アプライド メディカル リソーシーズ コーポレイション | Electrosurgical instrument with jaws and / or electrodes and electrosurgical amplifier |
US10470788B2 (en) * | 2010-12-07 | 2019-11-12 | Misonix, Inc | Ultrasonic instrument, associated method of use and related manufacturing method |
US8932279B2 (en) | 2011-04-08 | 2015-01-13 | Domain Surgical, Inc. | System and method for cooling of a heated surgical instrument and/or surgical site and treating tissue |
EP2704657A4 (en) | 2011-04-08 | 2014-12-31 | Domain Surgical Inc | Impedance matching circuit |
WO2012158722A2 (en) | 2011-05-16 | 2012-11-22 | Mcnally, David, J. | Surgical instrument guide |
US8232801B2 (en) | 2011-06-30 | 2012-07-31 | General Electric Company | Nuclear quadrupole resonance system and method for structural health monitoring |
ES2584388T3 (en) | 2011-07-27 | 2016-09-27 | Université Pierre Et Marie Curie (Paris 6) | Device for the treatment of a person's sensory capacity |
US9526558B2 (en) | 2011-09-13 | 2016-12-27 | Domain Surgical, Inc. | Sealing and/or cutting instrument |
US9655684B2 (en) * | 2011-09-30 | 2017-05-23 | Konica Minolta Laboratory U.S.A., Inc. | Catheter guidance system |
KR102151368B1 (en) | 2011-12-06 | 2020-09-04 | 도메인 서지컬, 인크. | System and method of controlling power delivery to a surgical instrument |
US10039586B2 (en) | 2013-02-26 | 2018-08-07 | Cpsi Holdings Llc | Ablation probe with deployable sensors |
US10314559B2 (en) | 2013-03-14 | 2019-06-11 | Inneroptic Technology, Inc. | Medical device guidance |
US10357306B2 (en) | 2014-05-14 | 2019-07-23 | Domain Surgical, Inc. | Planar ferromagnetic coated surgical tip and method for making |
KR102537276B1 (en) | 2014-05-16 | 2023-05-26 | 어플라이드 메디컬 리소시스 코포레이션 | Electrosurgical system |
KR102420273B1 (en) | 2014-05-30 | 2022-07-13 | 어플라이드 메디컬 리소시스 코포레이션 | Electrosurgical instrument for fusing and cutting tissue and an electrosurgical generator |
US9901406B2 (en) | 2014-10-02 | 2018-02-27 | Inneroptic Technology, Inc. | Affected region display associated with a medical device |
US10188467B2 (en) | 2014-12-12 | 2019-01-29 | Inneroptic Technology, Inc. | Surgical guidance intersection display |
US10420603B2 (en) | 2014-12-23 | 2019-09-24 | Applied Medical Resources Corporation | Bipolar electrosurgical sealer and divider |
USD748259S1 (en) | 2014-12-29 | 2016-01-26 | Applied Medical Resources Corporation | Electrosurgical instrument |
US9949700B2 (en) | 2015-07-22 | 2018-04-24 | Inneroptic Technology, Inc. | Medical device approaches |
US9675319B1 (en) | 2016-02-17 | 2017-06-13 | Inneroptic Technology, Inc. | Loupe display |
EP3426347A1 (en) | 2016-03-11 | 2019-01-16 | Sorbonne Universite | Implantable ultrasound generating treating device for spinal cord and/or spinal nerve treatment, apparatus comprising such device and method |
JP6772288B2 (en) | 2016-03-11 | 2020-10-21 | ソルボンヌ・ユニヴェルシテSorbonne Universite | An extracorporeal ultrasound generation therapy device for the treatment of the spinal cord and spinal nerves, a device equipped with the device, and a method using the device. |
US10278778B2 (en) | 2016-10-27 | 2019-05-07 | Inneroptic Technology, Inc. | Medical device navigation using a virtual 3D space |
US11259879B2 (en) | 2017-08-01 | 2022-03-01 | Inneroptic Technology, Inc. | Selective transparency to assist medical device navigation |
US11484365B2 (en) | 2018-01-23 | 2022-11-01 | Inneroptic Technology, Inc. | Medical image guidance |
AU2019335013A1 (en) | 2018-09-05 | 2021-03-25 | Applied Medical Resources Corporation | Electrosurgical generator control system |
EP3880099A1 (en) | 2018-11-16 | 2021-09-22 | Applied Medical Resources Corporation | Electrosurgical system |
US11020618B1 (en) * | 2020-06-25 | 2021-06-01 | AerWave Medical, Inc. | Method and apparatus for performance of thermal bronchioplasty to reduce covid-19-induced respiratory distress and treat covid-19-damaged distal lung regions |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5295484A (en) * | 1992-05-19 | 1994-03-22 | Arizona Board Of Regents For And On Behalf Of The University Of Arizona | Apparatus and method for intra-cardiac ablation of arrhythmias |
US5876399A (en) * | 1997-05-28 | 1999-03-02 | Irvine Biomedical, Inc. | Catheter system and methods thereof |
US6361531B1 (en) * | 2000-01-21 | 2002-03-26 | Medtronic Xomed, Inc. | Focused ultrasound ablation devices having malleable handle shafts and methods of using the same |
US20030040698A1 (en) * | 2001-06-29 | 2003-02-27 | Makin Inder Raj S. | Ultrasonic surgical instrument for intracorporeal sonodynamic therapy |
US20040054363A1 (en) * | 1996-10-22 | 2004-03-18 | Matthias Vaska | Methods and devices for ablation |
US20050261587A1 (en) * | 2004-05-20 | 2005-11-24 | Makin Inder R S | Ultrasound medical system and method |
US20050261585A1 (en) * | 2004-05-20 | 2005-11-24 | Makin Inder Raj S | Ultrasound medical system |
US7037306B2 (en) * | 2003-06-30 | 2006-05-02 | Ethicon, Inc. | System for creating linear lesions for the treatment of atrial fibrillation |
Family Cites Families (184)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3168659A (en) * | 1960-01-11 | 1965-02-02 | Gen Motors Corp | Variable focus transducer |
US3779234A (en) | 1971-06-30 | 1973-12-18 | Intersc Res Inst | Ultrasonic catheter with rotating transducers |
US3902501A (en) | 1973-06-21 | 1975-09-02 | Medtronic Inc | Endocardial electrode |
US3927557A (en) | 1974-05-30 | 1975-12-23 | Gen Electric | Acoustic imaging apparatus with liquid-filled acoustic corrector lens |
US4323077A (en) * | 1980-03-12 | 1982-04-06 | General Electric Company | Acoustic intensity monitor |
US4798215A (en) * | 1984-03-15 | 1989-01-17 | Bsd Medical Corporation | Hyperthermia apparatus |
US4315514A (en) * | 1980-05-08 | 1982-02-16 | William Drewes | Method and apparatus for selective cell destruction |
US4484569A (en) | 1981-03-13 | 1984-11-27 | Riverside Research Institute | Ultrasonic diagnostic and therapeutic transducer assembly and method for using |
EP0111386B1 (en) * | 1982-10-26 | 1987-11-19 | University Of Aberdeen | Ultrasound hyperthermia unit |
NL8302955A (en) * | 1983-08-24 | 1985-03-18 | Hoogovens Groep Bv | METHOD FOR MANUFACTURING A MAGNESIA CARBON STONE, MAGNESIA CARBON STONE MANUFACTURED BY THE METHOD AND CONVERTER CONTAINING A WEAR LINING, WHICH IS AT LEAST PART OF MAGNESIA CARBON STONES MADE WITH THE MAGNESIA |
US5150712A (en) | 1983-12-14 | 1992-09-29 | Edap International, S.A. | Apparatus for examining and localizing tumors using ultra sounds, comprising a device for localized hyperthermia treatment |
US5158070A (en) | 1983-12-14 | 1992-10-27 | Edap International, S.A. | Method for the localized destruction of soft structures using negative pressure elastic waves |
USRE33590E (en) * | 1983-12-14 | 1991-05-21 | Edap International, S.A. | Method for examining, localizing and treating with ultrasound |
US5143074A (en) | 1983-12-14 | 1992-09-01 | Edap International | Ultrasonic treatment device using a focussing and oscillating piezoelectric element |
US5143073A (en) * | 1983-12-14 | 1992-09-01 | Edap International, S.A. | Wave apparatus system |
US5150711A (en) | 1983-12-14 | 1992-09-29 | Edap International, S.A. | Ultra-high-speed extracorporeal ultrasound hyperthermia treatment device |
JPS61209643A (en) | 1985-03-15 | 1986-09-17 | 株式会社東芝 | Ultrasonic diagnostic and medical treatment apparatus |
JPH0653120B2 (en) | 1985-05-10 | 1994-07-20 | オリンパス光学工業株式会社 | Ultrasonic diagnostic equipment |
DE3604823C2 (en) * | 1986-02-15 | 1995-06-01 | Lindenmeier Heinz | High frequency generator with automatic power control for high frequency surgery |
JPS6346147A (en) | 1986-04-24 | 1988-02-27 | 株式会社東芝 | Ultrasonic remedy apparatus |
DE3663860D1 (en) | 1986-12-24 | 1989-07-13 | Hewlett Packard Gmbh | Method of and apparatus for adjusting the intensity profile of an ultrasound beam |
JPS63164944A (en) | 1986-12-26 | 1988-07-08 | 株式会社東芝 | Ultrasonic remedy apparatus |
US4844080A (en) | 1987-02-19 | 1989-07-04 | Michael Frass | Ultrasound contact medium dispenser |
US4984575A (en) * | 1987-04-16 | 1991-01-15 | Olympus Optical Co., Ltd. | Therapeutical apparatus of extracorporeal type |
DE3826709C2 (en) * | 1987-08-05 | 1994-12-22 | Toshiba Kawasaki Kk | Ultrasound therapy device |
FR2620294B1 (en) * | 1987-09-07 | 1990-01-19 | Technomed Int Sa | PIEZOELECTRIC DEVICE WITH REDUCED NEGATIVE WAVES, AND USE THEREOF FOR EXTRA-BODY LITHOTRITIS OR FOR THE DESTRUCTION OF SPECIAL TISSUES |
EP0310380B2 (en) | 1987-09-30 | 1997-04-02 | Kabushiki Kaisha Toshiba | Ultrasonic medical treatment apparatus |
DE3833309A1 (en) * | 1987-09-30 | 1989-04-20 | Toshiba Kawasaki Kk | Image processing device |
US4932414A (en) | 1987-11-02 | 1990-06-12 | Cornell Research Foundation, Inc. | System of therapeutic ultrasound and real-time ultrasonic scanning |
US4955366A (en) | 1987-11-27 | 1990-09-11 | Olympus Optical Co., Ltd. | Ultrasonic therapeutical apparatus |
US5209221A (en) * | 1988-03-01 | 1993-05-11 | Richard Wolf Gmbh | Ultrasonic treatment of pathological tissue |
US4951653A (en) | 1988-03-02 | 1990-08-28 | Laboratory Equipment, Corp. | Ultrasound brain lesioning system |
US5054470A (en) | 1988-03-02 | 1991-10-08 | Laboratory Equipment, Corp. | Ultrasonic treatment transducer with pressurized acoustic coupling |
US4955365A (en) | 1988-03-02 | 1990-09-11 | Laboratory Equipment, Corp. | Localization and therapy system for treatment of spatially oriented focal disease |
US5036855A (en) | 1988-03-02 | 1991-08-06 | Laboratory Equipment, Corp. | Localization and therapy system for treatment of spatially oriented focal disease |
US4858613A (en) | 1988-03-02 | 1989-08-22 | Laboratory Equipment, Corp. | Localization and therapy system for treatment of spatially oriented focal disease |
US5588432A (en) * | 1988-03-21 | 1996-12-31 | Boston Scientific Corporation | Catheters for imaging, sensing electrical potentials, and ablating tissue |
US5372138A (en) * | 1988-03-21 | 1994-12-13 | Boston Scientific Corporation | Acousting imaging catheters and the like |
DE3913023C2 (en) * | 1988-04-22 | 1993-10-14 | Toshiba Kawasaki Kk | Shatter wave treatment device |
US6027449A (en) * | 1988-05-11 | 2000-02-22 | Lunar Corporation | Ultrasonometer employing distensible membranes |
US5242437A (en) | 1988-06-10 | 1993-09-07 | Trimedyne Laser Systems, Inc. | Medical device applying localized high intensity light and heat, particularly for destruction of the endometrium |
US4960109A (en) | 1988-06-21 | 1990-10-02 | Massachusetts Institute Of Technology | Multi-purpose temperature sensing probe for hyperthermia therapy |
US5158071A (en) | 1988-07-01 | 1992-10-27 | Hitachi, Ltd. | Ultrasonic apparatus for therapeutical use |
US5374261A (en) * | 1990-07-24 | 1994-12-20 | Yoon; Inbae | Multifunctional devices for use in endoscopic surgical procedures and methods-therefor |
EP0355175A1 (en) | 1988-08-17 | 1990-02-28 | Siemens Aktiengesellschaft | Apparatus for the contactless disintegration of concrements in the body of a living being |
US5078144A (en) * | 1988-08-19 | 1992-01-07 | Olympus Optical Co. Ltd. | System for applying ultrasonic waves and a treatment instrument to a body part |
US5203333A (en) * | 1989-05-15 | 1993-04-20 | Kabushiki Kaisha Toshiba | Acoustic wave therapy apparatus |
JPH0323854A (en) * | 1989-06-21 | 1991-01-31 | Toshiba Corp | Shock wave treatment apparatus and continuous wave hyperthermia device |
US5435311A (en) | 1989-06-27 | 1995-07-25 | Hitachi, Ltd. | Ultrasound therapeutic system |
US5065761A (en) * | 1989-07-12 | 1991-11-19 | Diasonics, Inc. | Lithotripsy system |
EP0419729A1 (en) | 1989-09-29 | 1991-04-03 | Siemens Aktiengesellschaft | Position finding of a catheter by means of non-ionising fields |
US5149319A (en) | 1990-09-11 | 1992-09-22 | Unger Evan C | Methods for providing localized therapeutic heat to biological tissues and fluids |
US5148809A (en) | 1990-02-28 | 1992-09-22 | Asgard Medical Systems, Inc. | Method and apparatus for detecting blood vessels and displaying an enhanced video image from an ultrasound scan |
JPH03251240A (en) | 1990-02-28 | 1991-11-08 | Toshiba Corp | Ultrasonic medical treatment device |
DE69123864T2 (en) * | 1990-03-24 | 1997-08-14 | Toshiba Kawasaki Kk | Device for medical treatment with ultrasound waves |
US5117832A (en) | 1990-09-21 | 1992-06-02 | Diasonics, Inc. | Curved rectangular/elliptical transducer |
DE4037160A1 (en) | 1990-11-22 | 1992-05-27 | Dornier Medizintechnik | ACOUSTIC FOCUSING DEVICE |
US5269291A (en) | 1990-12-10 | 1993-12-14 | Coraje, Inc. | Miniature ultrasonic transducer for plaque ablation |
US5304115A (en) * | 1991-01-11 | 1994-04-19 | Baxter International Inc. | Ultrasonic angioplasty device incorporating improved transmission member and ablation probe |
US5316000A (en) | 1991-03-05 | 1994-05-31 | Technomed International (Societe Anonyme) | Use of at least one composite piezoelectric transducer in the manufacture of an ultrasonic therapy apparatus for applying therapy, in a body zone, in particular to concretions, to tissue, or to bones, of a living being and method of ultrasonic therapy |
DE4136004C1 (en) * | 1991-10-31 | 1993-01-28 | Siemens Ag, 8000 Muenchen, De | |
US5325860A (en) | 1991-11-08 | 1994-07-05 | Mayo Foundation For Medical Education And Research | Ultrasonic and interventional catheter and method |
US5524620A (en) | 1991-11-12 | 1996-06-11 | November Technologies Ltd. | Ablation of blood thrombi by means of acoustic energy |
US5238007A (en) | 1991-12-12 | 1993-08-24 | Vitatron Medical B.V. | Pacing lead with improved anchor mechanism |
JP3533217B2 (en) * | 1991-12-20 | 2004-05-31 | テクノメド メディカル システム | Ultrasound therapy device that outputs ultrasonic waves having thermal effect and cavitation effect |
FR2685872A1 (en) | 1992-01-07 | 1993-07-09 | Edap Int | APPARATUS OF EXTRACORPOREAL ULTRASONIC HYPERTHERMIA WITH VERY HIGH POWER AND ITS OPERATING METHOD. |
US5993389A (en) * | 1995-05-22 | 1999-11-30 | Ths International, Inc. | Devices for providing acoustic hemostasis |
JP3325300B2 (en) * | 1992-02-28 | 2002-09-17 | 株式会社東芝 | Ultrasound therapy equipment |
DE4207463C2 (en) * | 1992-03-10 | 1996-03-28 | Siemens Ag | Arrangement for the therapy of tissue with ultrasound |
WO1993019705A1 (en) | 1992-03-31 | 1993-10-14 | Massachusetts Institute Of Technology | Apparatus and method for acoustic heat generation and hyperthermia |
DE4213586C2 (en) | 1992-04-24 | 1995-01-19 | Siemens Ag | Therapy device for treatment with focused acoustic waves |
US5443470A (en) * | 1992-05-01 | 1995-08-22 | Vesta Medical, Inc. | Method and apparatus for endometrial ablation |
WO1994002077A2 (en) * | 1992-07-15 | 1994-02-03 | Angelase, Inc. | Ablation catheter system |
DE4229630C2 (en) * | 1992-09-04 | 1994-06-16 | Siemens Ag | Acoustic lens |
DE4229817C2 (en) | 1992-09-07 | 1996-09-12 | Siemens Ag | Method for the non-destructive and / or non-invasive measurement of a temperature change in the interior of a living object in particular |
US5391197A (en) * | 1992-11-13 | 1995-02-21 | Dornier Medical Systems, Inc. | Ultrasound thermotherapy probe |
US5620479A (en) * | 1992-11-13 | 1997-04-15 | The Regents Of The University Of California | Method and apparatus for thermal therapy of tumors |
US5733315A (en) * | 1992-11-13 | 1998-03-31 | Burdette; Everette C. | Method of manufacture of a transurethral ultrasound applicator for prostate gland thermal therapy |
DE4238645C1 (en) | 1992-11-16 | 1994-05-05 | Siemens Ag | Therapeutic ultrasonic applicator for urogenital area - has ultrasonic waves focussed onto working zone defined by envelope curve with two perpendicular main axes |
US5348017A (en) | 1993-01-19 | 1994-09-20 | Cardiovascular Imaging Systems, Inc. | Drive shaft for an intravascular catheter system |
US5738635A (en) * | 1993-01-22 | 1998-04-14 | Technomed Medical Systems | Adjustable focusing therapeutic apparatus with no secondary focusing |
US5573497A (en) * | 1994-11-30 | 1996-11-12 | Technomed Medical Systems And Institut National | High-intensity ultrasound therapy method and apparatus with controlled cavitation effect and reduced side lobes |
DE4302537C1 (en) * | 1993-01-29 | 1994-04-28 | Siemens Ag | Ultrasound imaging and therapy device - generates imaging waves and focussed treatment waves having two differing frequencies for location and treatment of e.g tumours |
DE4302538C1 (en) | 1993-01-29 | 1994-04-07 | Siemens Ag | Ultrasonic therapy device for tumour treatment lithotripsy or osteorestoration - with ultrasonic imaging and ultrasonic treatment modes using respective acoustic wave frequencies |
US6010531A (en) * | 1993-02-22 | 2000-01-04 | Heartport, Inc. | Less-invasive devices and methods for cardiac valve surgery |
JP3860227B2 (en) * | 1993-03-10 | 2006-12-20 | 株式会社東芝 | Ultrasonic therapy device used under MRI guide |
US5553618A (en) | 1993-03-12 | 1996-09-10 | Kabushiki Kaisha Toshiba | Method and apparatus for ultrasound medical treatment |
DE4309596A1 (en) * | 1993-03-22 | 1994-09-29 | Kari Dr Richter | Process for imaging using echo signals |
JPH06285106A (en) * | 1993-03-30 | 1994-10-11 | Shimadzu Corp | Ultrasonic therapeutic device |
US5462522A (en) | 1993-04-19 | 1995-10-31 | Olympus Optical Co., Ltd. | Ultrasonic therapeutic apparatus |
US5465724A (en) | 1993-05-28 | 1995-11-14 | Acuson Corporation | Compact rotationally steerable ultrasound transducer |
US5571088A (en) | 1993-07-01 | 1996-11-05 | Boston Scientific Corporation | Ablation catheters |
US5630837A (en) * | 1993-07-01 | 1997-05-20 | Boston Scientific Corporation | Acoustic ablation |
US5860974A (en) * | 1993-07-01 | 1999-01-19 | Boston Scientific Corporation | Heart ablation catheter with expandable electrode and method of coupling energy to an electrode on a catheter shaft |
WO1995001751A1 (en) * | 1993-07-01 | 1995-01-19 | Boston Scientific Corporation | Imaging, electrical potential sensing, and ablation catheters |
US5413550A (en) * | 1993-07-21 | 1995-05-09 | Pti, Inc. | Ultrasound therapy system with automatic dose control |
WO1995002994A1 (en) * | 1993-07-26 | 1995-02-02 | Innelect | Imaging and therapy intraluminal probe and therapeutic treatment apparatus utilizing same |
US5398691A (en) * | 1993-09-03 | 1995-03-21 | University Of Washington | Method and apparatus for three-dimensional translumenal ultrasonic imaging |
US5458597A (en) * | 1993-11-08 | 1995-10-17 | Zomed International | Device for treating cancer and non-malignant tumors and methods |
US5471988A (en) | 1993-12-24 | 1995-12-05 | Olympus Optical Co., Ltd. | Ultrasonic diagnosis and therapy system in which focusing point of therapeutic ultrasonic wave is locked at predetermined position within observation ultrasonic scanning range |
US5873828A (en) * | 1994-02-18 | 1999-02-23 | Olympus Optical Co., Ltd. | Ultrasonic diagnosis and treatment system |
US5526822A (en) | 1994-03-24 | 1996-06-18 | Biopsys Medical, Inc. | Method and apparatus for automated biopsy and collection of soft tissue |
JP3248344B2 (en) * | 1994-04-07 | 2002-01-21 | 富士写真光機株式会社 | Insertable ultrasonic diagnostic equipment |
US5492126A (en) * | 1994-05-02 | 1996-02-20 | Focal Surgery | Probe for medical imaging and therapy using ultrasound |
US5549638A (en) | 1994-05-17 | 1996-08-27 | Burdette; Everette C. | Ultrasound device for use in a thermotherapy apparatus |
US5505730A (en) | 1994-06-24 | 1996-04-09 | Stuart D. Edwards | Thin layer ablation apparatus |
US5746224A (en) * | 1994-06-24 | 1998-05-05 | Somnus Medical Technologies, Inc. | Method for ablating turbinates |
US5545195A (en) | 1994-08-01 | 1996-08-13 | Boston Scientific Corporation | Interstitial heating of tissue |
US5398690A (en) * | 1994-08-03 | 1995-03-21 | Batten; Bobby G. | Slaved biopsy device, analysis apparatus, and process |
US5743862A (en) * | 1994-09-19 | 1998-04-28 | Kabushiki Kaisha Toshiba | Ultrasonic medical treatment apparatus |
US5606975A (en) * | 1994-09-19 | 1997-03-04 | The Board Of Trustees Of The Leland Stanford Junior University | Forward viewing ultrasonic imaging catheter |
US5514130A (en) * | 1994-10-11 | 1996-05-07 | Dorsal Med International | RF apparatus for controlled depth ablation of soft tissue |
US5547459A (en) | 1994-10-25 | 1996-08-20 | Orthologic Corporation | Ultrasonic bone-therapy apparatus and method |
US5575789A (en) | 1994-10-27 | 1996-11-19 | Valleylab Inc. | Energizable surgical tool safety device and method |
US5520188A (en) * | 1994-11-02 | 1996-05-28 | Focus Surgery Inc. | Annular array transducer |
US5628743A (en) * | 1994-12-21 | 1997-05-13 | Valleylab Inc. | Dual mode ultrasonic surgical apparatus |
US5873902A (en) * | 1995-03-31 | 1999-02-23 | Focus Surgery, Inc. | Ultrasound intensity determining method and apparatus |
US5626607A (en) * | 1995-04-03 | 1997-05-06 | Heartport, Inc. | Clamp assembly and method of use |
US6056735A (en) * | 1996-04-04 | 2000-05-02 | Olympus Optical Co., Ltd. | Ultrasound treatment system |
US5735280A (en) * | 1995-05-02 | 1998-04-07 | Heart Rhythm Technologies, Inc. | Ultrasound energy delivery system and method |
US5558092A (en) | 1995-06-06 | 1996-09-24 | Imarx Pharmaceutical Corp. | Methods and apparatus for performing diagnostic and therapeutic ultrasound simultaneously |
US6726677B1 (en) * | 1995-10-13 | 2004-04-27 | Transvascular, Inc. | Stabilized tissue penetrating catheters |
US5590657A (en) * | 1995-11-06 | 1997-01-07 | The Regents Of The University Of Michigan | Phased array ultrasound system and method for cardiac ablation |
US5895356A (en) * | 1995-11-15 | 1999-04-20 | American Medical Systems, Inc. | Apparatus and method for transurethral focussed ultrasound therapy |
DE19644314A1 (en) * | 1995-11-23 | 1997-05-28 | Siemens Ag | Therapy appts. with acoustic wave source |
US5728062A (en) * | 1995-11-30 | 1998-03-17 | Pharmasonics, Inc. | Apparatus and methods for vibratory intraluminal therapy employing magnetostrictive transducers |
US5800379A (en) * | 1996-02-23 | 1998-09-01 | Sommus Medical Technologies, Inc. | Method for ablating interior sections of the tongue |
US6033397A (en) * | 1996-03-05 | 2000-03-07 | Vnus Medical Technologies, Inc. | Method and apparatus for treating esophageal varices |
US6024718A (en) * | 1996-09-04 | 2000-02-15 | The Regents Of The University Of California | Intraluminal directed ultrasound delivery device |
US6216704B1 (en) * | 1997-08-13 | 2001-04-17 | Surx, Inc. | Noninvasive devices, methods, and systems for shrinking of tissues |
DE19648338C2 (en) * | 1996-11-22 | 2001-02-01 | Wolf Gmbh Richard | Device for tracking a target for a therapy device |
US6086539A (en) * | 1996-12-04 | 2000-07-11 | Acuson Corporation | Methods and apparatus for ultrasound image quantification |
US6030344A (en) * | 1996-12-04 | 2000-02-29 | Acuson Corporation | Methods and apparatus for ultrasound image quantification |
US6045508A (en) * | 1997-02-27 | 2000-04-04 | Acuson Corporation | Ultrasonic probe, system and method for two-dimensional imaging or three-dimensional reconstruction |
US5873845A (en) * | 1997-03-17 | 1999-02-23 | General Electric Company | Ultrasound transducer with focused ultrasound refraction plate |
EP0873722A1 (en) * | 1997-04-24 | 1998-10-28 | Sulzer Osypka GmbH | Apparatus for an endocardiac treatment |
US5906580A (en) * | 1997-05-05 | 1999-05-25 | Creare Inc. | Ultrasound system and method of administering ultrasound including a plurality of multi-layer transducer elements |
US6024740A (en) * | 1997-07-08 | 2000-02-15 | The Regents Of The University Of California | Circumferential ablation device assembly |
FR2764516B1 (en) * | 1997-06-11 | 1999-09-03 | Inst Nat Sante Rech Med | ULTRASONIC INTRATISSULAIRE APPLICATOR FOR HYPERTHERMIA |
US6547788B1 (en) * | 1997-07-08 | 2003-04-15 | Atrionx, Inc. | Medical device with sensor cooperating with expandable member |
US5893835A (en) * | 1997-10-10 | 1999-04-13 | Ethicon Endo-Surgery, Inc. | Ultrasonic clamp coagulator apparatus having dual rotational positioning |
US6050943A (en) * | 1997-10-14 | 2000-04-18 | Guided Therapy Systems, Inc. | Imaging, therapy, and temperature monitoring ultrasonic system |
US6013031A (en) * | 1998-03-09 | 2000-01-11 | Mendlein; John D. | Methods and devices for improving ultrasonic measurements using anatomic landmarks and soft tissue correction |
US6039689A (en) * | 1998-03-11 | 2000-03-21 | Riverside Research Institute | Stripe electrode transducer for use with therapeutic ultrasonic radiation treatment |
US5897523A (en) * | 1998-04-13 | 1999-04-27 | Ethicon Endo-Surgery, Inc. | Articulating ultrasonic surgical instrument |
US6193709B1 (en) * | 1998-05-13 | 2001-02-27 | Olympus Optical Co., Ltd. | Ultrasonic treatment apparatus |
US6740082B2 (en) * | 1998-12-29 | 2004-05-25 | John H. Shadduck | Surgical instruments for treating gastro-esophageal reflux |
US6112123A (en) * | 1998-07-28 | 2000-08-29 | Endonetics, Inc. | Device and method for ablation of tissue |
US6059731A (en) * | 1998-08-19 | 2000-05-09 | Mayo Foundation For Medical Education And Research | Simultaneous side-and-end viewing underfluid catheter |
US6042556A (en) * | 1998-09-04 | 2000-03-28 | University Of Washington | Method for determining phase advancement of transducer elements in high intensity focused ultrasound |
US6425867B1 (en) * | 1998-09-18 | 2002-07-30 | University Of Washington | Noise-free real time ultrasonic imaging of a treatment site undergoing high intensity focused ultrasound therapy |
AU1442500A (en) * | 1998-10-05 | 2000-04-26 | Scimed Life Systems, Inc. | Large area thermal ablation |
US6540700B1 (en) * | 1998-10-26 | 2003-04-01 | Kabushiki Kaisha Toshiba | Ultrasound treatment apparatus |
GB9901306D0 (en) * | 1999-01-21 | 1999-03-10 | Smythe David | 3D/4D ultrasound imaging system |
US6206843B1 (en) * | 1999-01-28 | 2001-03-27 | Ultra Cure Ltd. | Ultrasound system and methods utilizing same |
US6682483B1 (en) * | 1999-05-28 | 2004-01-27 | Vuesonix Sensors, Inc. | Device and method for mapping and tracking blood flow and determining parameters of blood flow |
US6626899B2 (en) * | 1999-06-25 | 2003-09-30 | Nidus Medical, Llc | Apparatus and methods for treating tissue |
US6340348B1 (en) * | 1999-07-02 | 2002-01-22 | Acuson Corporation | Contrast agent imaging with destruction pulses in diagnostic medical ultrasound |
US6371973B1 (en) * | 1999-08-04 | 2002-04-16 | Ron-Tech Medical Ltd. | Forceps useful for intrabody guiding and/or positioning of a medical instrument |
US6210330B1 (en) * | 1999-08-04 | 2001-04-03 | Rontech Medical Ltd. | Apparatus, system and method for real-time endovaginal sonography guidance of intra-uterine, cervical and tubal procedures |
US6352532B1 (en) * | 1999-12-14 | 2002-03-05 | Ethicon Endo-Surgery, Inc. | Active load control of ultrasonic surgical instruments |
WO2001045550A2 (en) * | 1999-12-23 | 2001-06-28 | Therus Corporation | Ultrasound transducers for imaging and therapy |
JP2001212144A (en) * | 2000-01-31 | 2001-08-07 | Toshiba Corp | Ultrasonic diagnostic apparatus and ultrasonic imaging method |
IL139788A (en) * | 2000-11-20 | 2006-10-05 | Minelu Zonnenschein | Stapler for endoscopes |
US6546935B2 (en) * | 2000-04-27 | 2003-04-15 | Atricure, Inc. | Method for transmural ablation |
US6371903B1 (en) * | 2000-06-22 | 2002-04-16 | Technomed Medical Systems, S.A. | Therapy probe |
JP3844663B2 (en) * | 2001-05-07 | 2006-11-15 | ジーイー・メディカル・システムズ・グローバル・テクノロジー・カンパニー・エルエルシー | Ultrasonic diagnostic equipment |
US20030069502A1 (en) * | 2001-05-29 | 2003-04-10 | Makin Inder Raj. S. | Ultrasound feedback in medically-treated patients |
US7035166B2 (en) * | 2002-10-21 | 2006-04-25 | Farsounder, Inc. | 3-D forward looking sonar with fixed frame of reference for navigation |
US6709397B2 (en) * | 2001-10-16 | 2004-03-23 | Envisioneering, L.L.C. | Scanning probe |
WO2003051208A1 (en) * | 2001-12-14 | 2003-06-26 | Ekos Corporation | Blood flow reestablishment determination |
IL148299A (en) * | 2002-02-21 | 2014-04-30 | Technion Res & Dev Foundation | Ultrasound cardiac stimulator |
US6887239B2 (en) * | 2002-04-17 | 2005-05-03 | Sontra Medical Inc. | Preparation for transmission and reception of electrical signals |
US20040006336A1 (en) * | 2002-07-02 | 2004-01-08 | Scimed Life Systems, Inc. | Apparatus and method for RF ablation into conductive fluid-infused tissue |
JP3728283B2 (en) * | 2002-08-30 | 2005-12-21 | キヤノン株式会社 | Recording device |
US20050228286A1 (en) * | 2004-04-07 | 2005-10-13 | Messerly Jeffrey D | Medical system having a rotatable ultrasound source and a piercing tip |
US7494467B2 (en) * | 2004-04-16 | 2009-02-24 | Ethicon Endo-Surgery, Inc. | Medical system having multiple ultrasound transducers or an ultrasound transducer and an RF electrode |
US7695436B2 (en) * | 2004-05-21 | 2010-04-13 | Ethicon Endo-Surgery, Inc. | Transmit apodization of an ultrasound transducer array |
US7473250B2 (en) * | 2004-05-21 | 2009-01-06 | Ethicon Endo-Surgery, Inc. | Ultrasound medical system and method |
US20050261588A1 (en) * | 2004-05-21 | 2005-11-24 | Makin Inder Raj S | Ultrasound medical system |
US7474224B2 (en) * | 2004-09-08 | 2009-01-06 | Smart Caregiver Corporation | Patient monitor with magnetic disarming circuit |
US20070016184A1 (en) * | 2005-07-14 | 2007-01-18 | Ethicon Endo-Surgery, Inc. | Medical-treatment electrode assembly and method for medical treatment |
WO2007021958A2 (en) * | 2005-08-12 | 2007-02-22 | University Of Washington | Method and apparatus for preparing organs and tissues for laparoscopic surgery |
US8025672B2 (en) * | 2006-08-29 | 2011-09-27 | Misonix, Incorporated | Ultrasonic wound treatment method and apparatus |
-
2004
- 2004-05-21 US US10/850,984 patent/US7473250B2/en active Active
-
2008
- 2008-06-25 US US12/145,635 patent/US20080287837A1/en not_active Abandoned
-
2013
- 2013-01-28 US US13/752,151 patent/US20130218013A1/en not_active Abandoned
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5295484A (en) * | 1992-05-19 | 1994-03-22 | Arizona Board Of Regents For And On Behalf Of The University Of Arizona | Apparatus and method for intra-cardiac ablation of arrhythmias |
US20040054363A1 (en) * | 1996-10-22 | 2004-03-18 | Matthias Vaska | Methods and devices for ablation |
US5876399A (en) * | 1997-05-28 | 1999-03-02 | Irvine Biomedical, Inc. | Catheter system and methods thereof |
US6361531B1 (en) * | 2000-01-21 | 2002-03-26 | Medtronic Xomed, Inc. | Focused ultrasound ablation devices having malleable handle shafts and methods of using the same |
US20030040698A1 (en) * | 2001-06-29 | 2003-02-27 | Makin Inder Raj S. | Ultrasonic surgical instrument for intracorporeal sonodynamic therapy |
US7037306B2 (en) * | 2003-06-30 | 2006-05-02 | Ethicon, Inc. | System for creating linear lesions for the treatment of atrial fibrillation |
US20050261587A1 (en) * | 2004-05-20 | 2005-11-24 | Makin Inder R S | Ultrasound medical system and method |
US20050261585A1 (en) * | 2004-05-20 | 2005-11-24 | Makin Inder Raj S | Ultrasound medical system |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10993699B2 (en) | 2011-10-28 | 2021-05-04 | Decision Sciences International Corporation | Spread spectrum coded waveforms in ultrasound diagnostics |
US11596388B2 (en) | 2011-10-28 | 2023-03-07 | Decision Sciences International Corporation | Spread spectrum coded waveforms in ultrasound diagnostics |
US11096661B2 (en) | 2013-09-13 | 2021-08-24 | Decision Sciences International Corporation | Coherent spread-spectrum coded waveforms in synthetic aperture image formation |
US11607192B2 (en) | 2013-09-13 | 2023-03-21 | Decision Sciences International Corporation | Coherent spread-spectrum coded waveforms in synthetic aperture image formation |
US10743838B2 (en) | 2015-02-25 | 2020-08-18 | Decision Sciences Medical Company, LLC | Acoustic signal transmission couplants and coupling mediums |
US11191521B2 (en) | 2015-02-25 | 2021-12-07 | Decision Sciences Medical Company, LLC | Acoustic signal transmission couplants and coupling mediums |
US11839512B2 (en) | 2015-02-25 | 2023-12-12 | Decision Sciences Medical Company, LLC | Acoustic signal transmission couplants and coupling mediums |
US10426429B2 (en) | 2015-10-08 | 2019-10-01 | Decision Sciences Medical Company, LLC | Acoustic orthopedic tracking system and methods |
US11737726B2 (en) | 2015-10-08 | 2023-08-29 | Decision Sciences Medical Company, LLC | Acoustic orthopedic tracking system and methods |
US11154274B2 (en) | 2019-04-23 | 2021-10-26 | Decision Sciences Medical Company, LLC | Semi-rigid acoustic coupling articles for ultrasound diagnostic and treatment applications |
US11520043B2 (en) | 2020-11-13 | 2022-12-06 | Decision Sciences Medical Company, LLC | Systems and methods for synthetic aperture ultrasound imaging of an object |
US11957516B2 (en) | 2023-02-27 | 2024-04-16 | Decision Sciences International Corporation | Spread spectrum coded waveforms in ultrasound diagnostics |
Also Published As
Publication number | Publication date |
---|---|
US20050261611A1 (en) | 2005-11-24 |
US7473250B2 (en) | 2009-01-06 |
US20080287837A1 (en) | 2008-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7473250B2 (en) | Ultrasound medical system and method | |
US7951095B2 (en) | Ultrasound medical system | |
US20050261588A1 (en) | Ultrasound medical system | |
US11690662B2 (en) | Cryogenic balloon device with radiofrequency treatment region | |
US8007497B2 (en) | Ablation probe with heat sink | |
US20050228286A1 (en) | Medical system having a rotatable ultrasound source and a piercing tip | |
US7361174B2 (en) | Angle indexer for medical devices | |
US9566113B2 (en) | Low power tissue ablation system | |
JP4280865B2 (en) | Transcutaneous pringle occlusion device | |
US8439907B2 (en) | Hemostatic tissue tunnel generator for inserting treatment apparatus into tissue of a patient | |
KR101330755B1 (en) | Ablation instruments and related methods | |
EP2759276A1 (en) | Ablation catheter | |
JP2002531165A (en) | Internal mechanism for moving slidable electrodes | |
US20050085726A1 (en) | Therapy probe | |
JP2002511302A (en) | Electrocautery catheter | |
JP2005505328A (en) | System and method for mapping and ablation of biological tissue in an internal region of the heart | |
JP2004535860A (en) | Treatment of lung lesions using ultrasound | |
JP2005270662A (en) | Phased-array for tissue treatment | |
WO1995005124A1 (en) | Steerable medical probe with stylets | |
CA2584016A1 (en) | Ablation catheter | |
US20090198156A1 (en) | Ultrasound medical treatment system and method | |
CA2727025A1 (en) | Handheld system and method for delivering energy to tissue | |
US20050261587A1 (en) | Ultrasound medical system and method | |
US20140243810A1 (en) | Catheter assembly for treatment of hypertrophic tissue |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |